Post-LASIK patient dissatisfaction

Article

People who are dissatisfied with the results of LASIK are more likely to be referred to a cornea service by their doctor than by their LASIK surgeon.

People who are dissatisfied with the results of LASIK are more likely to be referred to a cornea service by their doctor than by their LASIK surgeon, according to the results of a study published in the January issue of the Journal of Cataract and Refractive Surgery.

Brett Levinson and colleagues from the Wills Eye Institute, Pennsylvania, USA conducted a retrospective chart review of all patients seen for consultation between January 2004 and December 2006, who had had LASIK performed elsewhere.

A total of 157 eyes of 109 patients were included in the study. Twenty-eight percent of subjects were referred by their LASIK surgeon, 54% by another eye doctor and 17% were self-referred. The most common complaints were poor distance vision (63%), dry eye (19%), redness/pain (7%) and glare/halos (5%). Forty-four eyes (28%) had surgical complications or enhancements. The most common diagnoses were dry eye or blepharitis (27.8%), irregular astigmatism (12.1%) and epithelial in-growth (9.1%). Medical management was offered in 39% of cases, surgical intervention in 27% and observation only in 7%. Non-surgical therapy was offered in 73% of cases.

The results of this study demonstrate that poor distance vision, dry eye, redness/pain and glare/halos are the most common reason for a referral to a cornea specialist after LASIK and that patients are more likely to be referred to such a service by a doctor other than their LASIK surgeon.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.